SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 47 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,585,000 | -4.5% | 2,060,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,706,000 | -85.2% | 2,060,000 | -83.5% | 0.00% | -85.0% |
| Q4 2021 | $18,337,000 | -22.6% | 12,500,000 | -21.9% | 0.02% | -25.9% |
| Q3 2021 | $23,700,000 | +3.5% | 16,000,000 | -8.6% | 0.03% | -3.6% |
| Q1 2021 | $22,903,000 | -58.5% | 17,500,000 | -22.2% | 0.03% | -60.0% |
| Q4 2020 | $55,221,000 | +32.2% | 22,500,000 | +11.8% | 0.07% | +18.6% |
| Q3 2020 | $41,779,000 | +102.1% | 20,125,000 | +123.6% | 0.06% | +84.4% |
| Q2 2020 | $20,677,000 | +36.0% | 9,000,000 | -10.0% | 0.03% | +14.3% |
| Q1 2020 | $15,203,000 | +212.3% | 10,000,000 | +300.0% | 0.03% | +300.0% |
| Q4 2019 | $4,868,000 | -88.5% | 2,500,000 | -86.8% | 0.01% | -89.9% |
| Q2 2019 | $42,340,000 | +55.8% | 19,000,000 | +26.6% | 0.07% | +56.8% |
| Q1 2019 | $27,181,000 | – | 15,012,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 61,662,000 | $141,593,000 | 5.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 93,891,000 | $215,954,000 | 2.17% |
| LINDEN ADVISORS LP | 30,877,000 | $71,021,000 | 1.15% |
| Verition Fund Management LLC | 14,948,000 | $34,343,000 | 1.13% |
| SSI INVESTMENT MANAGEMENT LLC | 5,167,000 | $11,858,000 | 1.04% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $17,246,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 11,929,000 | $27,313,000 | 0.64% |
| CSS LLC/IL | 4,144,000 | $9,531,000 | 0.54% |
| AQR Arbitrage LLC | 4,625,000 | $10,626,000 | 0.47% |
| Calamos Advisors LLC | 25,136,000 | $57,829,000 | 0.41% |